Volker Thiel mostly deals with Virology, Coronavirus, Interferon, RNA and Viral replication. Volker Thiel is involved in the study of Virology that focuses on Virus in particular. His Coronavirus research is multidisciplinary, relying on both Respiratory disease, Viral evolution, Genome, Subgenomic mRNA and Middle East respiratory syndrome.
His Interferon study combines topics in areas such as Open reading frame, Innate immune system, Disease reservoir and Recombinant DNA. His research investigates the link between RNA and topics such as Transcription that cross with problems in RNA Helicase A and Primase. Volker Thiel combines subjects such as Severe disease, Mouse hepatitis virus and Severe acute respiratory syndrome coronavirus 2 with his study of Viral replication.
Volker Thiel focuses on Virology, Coronavirus, Virus, Viral replication and RNA. Volker Thiel does research in Virology, focusing on Interferon specifically. Volker Thiel interconnects Genetics, Gene, RNA-dependent RNA polymerase, Coronaviridae and Human coronavirus 229E in the investigation of issues within Coronavirus.
In his study, Complementary DNA is strongly linked to Vaccinia, which falls under the umbrella field of Virus. His Viral replication research incorporates themes from Transmission, Tropism, Respiratory tract and Microbiology. His study in RNA is interdisciplinary in nature, drawing from both Organelle and Cell biology.
Volker Thiel spends much of his time researching Coronavirus, Virology, Virus, Severe acute respiratory syndrome coronavirus 2 and Cell biology. His Coronavirus research incorporates elements of Complementary DNA, Middle East respiratory syndrome, Endoribonuclease, Computational biology and Human coronavirus 229E. Volker Thiel is studying Viral replication, which is a component of Virology.
His Virus research includes elements of Cell, Epithelium, Respiratory epithelium, Ex vivo and Innate immune system. His Cell biology research includes themes of RNA and Stress granule, Messenger RNA, Translation. In the subject of general RNA, his work in RNase P is often linked to RNA silencing, thereby combining diverse domains of study.
His primary areas of study are Coronavirus, Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019 and Virus. The various areas that Volker Thiel examines in his Coronavirus study include RNA, Viral pathogenesis, Viral replication and Middle East respiratory syndrome. His work in Viral pathogenesis addresses issues such as Pathogenesis, which are connected to fields such as Knockout mouse and Middle East respiratory syndrome coronavirus.
His research investigates the connection with Middle East respiratory syndrome and areas like Mutant which intersect with concerns in Messenger RNA. His Virology research integrates issues from Immunoassay, Serology, Seroprevalence and Immunity. The various areas that Volker Thiel examines in his Virus study include Transcriptome, Computational biology, Plasma protein binding and Innate immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.
Eric J. Snijder;Peter J. Bredenbeek;Jessika C. Dobbe;Volker Thiel.
Journal of Molecular Biology (2003)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj;Huihui Mou;Saskia L. Smits;Dick H. W. Dekkers.
Nature (2013)
Mechanisms and enzymes involved in SARS coronavirus genome expression.
Volker Thiel;Konstantin A. Ivanov;Ákos Putics;Tobias Hertzig.
Journal of General Virology (2003)
2′- O methylation of the viral mRNA cap evades host restriction by IFIT family members
Stephane Daffis;Kristy J. Szretter;Jill Schriewer;Jianqing Li.
Nature (2010)
Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
Roland Züst;Roland Züst;Luisa Cervantes-Barragan;Matthias Habjan;Reinhard Maier.
Nature Immunology (2011)
Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus
Volker Thiel;Jens Herold;Barbara Schelle;Stuart G. Siddell.
Journal of General Virology (2001)
Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase
Konstantin A. Ivanov;Volker Thiel;Jessika C. Dobbe;Yvonne van der Meer.
Journal of Virology (2004)
The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
Susanne Pfefferle;Julia Schöpf;Manfred Kögl;Caroline C. Friedel;Caroline C. Friedel.
PLOS Pathogens (2011)
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon.
Luisa Cervantes-Barragan;Roland Züst;Friedemann Weber;Martin Spiegel.
Blood (2007)
Major genetic marker of nidoviruses encodes a replicative endoribonuclease
Konstantin A. Ivanov;Tobias Hertzig;Mikhail Rozanov;Sonja Bayer.
Proceedings of the National Academy of Sciences of the United States of America (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Kantonsspital St. Gallen
Charité - University Medicine Berlin
University of Bristol
University of Giessen
Charité - University Medicine Berlin
University of Giessen
Ruhr University Bochum
Hannover Medical School
Charité - University Medicine Berlin
German Primate Center
Wilfrid Laurier University
McGill University
Utrecht University
Nagoya University
Harbin Normal University
Los Alamos National Laboratory
Mayo Clinic
Institut de Recherches Internationales Servier
The University of Texas Southwestern Medical Center
National Institutes of Health
University of Oslo
National Center for Atmospheric Research
University of Pittsburgh
Columbia University
University of Minnesota
University of Amsterdam